The safety and efficacy of endoscopic submucosal dissection for superficial pharyngeal squamous cell neoplasms: a single-center study in China
- PMID: 40259092
- DOI: 10.1007/s00464-025-11636-1
The safety and efficacy of endoscopic submucosal dissection for superficial pharyngeal squamous cell neoplasms: a single-center study in China
Abstract
Background and aims: Endoscopic submucosal dissection (ESD) is a mainstream treatment for superficial pharyngeal squamous cell neoplasms (SPSCN) in Japan. There were few reports of it in China, which were small in scale and lack long-term follow-up data. Quality of life (QoL) outcomes of ESD for SPSCN have also not been studied. The aims of this study were to clarify the safety and efficacy of ESD for SPSCN and its outcomes in the Chinese setting.
Methods: Eighty-four consecutive patients with 145 lesions treated with ESD for SPSCN from January 2014 to August 2022 were enrolled. Their curability, complications, metachronous SPSCN, local recurrence, lymph node metastasis, and overall and disease-specific survival rates were analyzed. The quality of life was measured by MD Anderson Symptom Inventory-Head and Neck (MDASI-HN).
Results: The en-bloc resection rate was 94.5%, and the R0 resection rate was 74.5%. The postoperative adverse event rate was 2.6%. The median follow-up period was 36.28 months. The 3-year rates of metachronous pharyngeal cancer, local recurrence, lymph node metastasis, overall survival, and disease-specific survival were 14.1%, 7.6%, 9.6%, 92.4%, and 98.0%, respectively. The mean symptom composite score and interference score of MDASI-HN were 10.3 and 2.3, respectively.
Conclusions: In the Chinese setting, pharyngeal ESD achieves curability, safety, and long-term outcomes comparable to those observed in Japan. The postoperative QoL is satisfactory.
Keywords: Efficacy; Endoscopic submucosal dissection; Quality of life; Safety; Superficial pharyngeal squamous cell neoplasm.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Disclosures: Xinghang Dai, Yi Liu, Lizhou Dou, Yueming Zhang, Yong Liu, Shibo Song, Guiqi Wang, and Shun He declare no conflict of interest.
Similar articles
-
Efficacy of double-scope endoscopic submucosal dissection and long-term outcomes of endoscopic resection for superficial pharyngeal cancer.Dig Endosc. 2017 Mar;29(2):152-159. doi: 10.1111/den.12712. Epub 2016 Sep 13. Dig Endosc. 2017. PMID: 27525634
-
Clinicopathological Features and Outcomes of Endoscopic Submucosal Dissection for Superficial Cancer of the Pharynx.Acta Med Okayama. 2019 Apr;73(2):109-115. doi: 10.18926/AMO/56646. Acta Med Okayama. 2019. PMID: 31015745
-
Effectiveness and outcomes of endoscopic resection for superficial pharyngeal squamous cell carcinomas.Head Neck. 2025 Feb;47(2):463-471. doi: 10.1002/hed.27924. Epub 2024 Aug 29. Head Neck. 2025. PMID: 39210552
-
Efficacy and safety of endoscopic submucosal dissection versus endoscopic mucosal resection for superficial esophageal carcinoma: a systematic review and meta-analysis.Dis Esophagus. 2021 Apr 7;34(4):doaa081. doi: 10.1093/dote/doaa081. Dis Esophagus. 2021. PMID: 32895709
-
Endoscopic submucosal dissection for superficial esophageal cancer.Dis Esophagus. 2018 Jul 1;31(7). doi: 10.1093/dote/doy021. Dis Esophagus. 2018. PMID: 29982386 Review.
Cited by
-
Short- and long-term outcomes of endoscopic submucosal dissection for superficial pharyngeal squamous cell carcinoma in older adult patients.Surg Endosc. 2025 Jul 23. doi: 10.1007/s00464-025-11996-8. Online ahead of print. Surg Endosc. 2025. PMID: 40699343
References
-
- Garneau JC, Bakst RL, Miles BA (2018) Hypopharyngeal cancer: a state of the art review. Oral Oncol 86:244–250. https://doi.org/10.1016/j.oraloncology.2018.09.025 - DOI - PubMed
-
- Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S et al (2010) Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 28(9):1566–1572. https://doi.org/10.1200/JCO.2009.25.4680 - DOI - PubMed - PMC
-
- Maekawa A, Ishihara R, Iwatsubo T, Nakagawa K, Ohmori M, Iwagami H et al (2020) High incidence of head and neck cancers after endoscopic resection for esophageal cancer in younger patients. J Gastroenterol 55(4):401–407. https://doi.org/10.1007/s00535-019-01653-y - DOI - PubMed
-
- Abe M, Iwamuro M, Kawahara Y, Kanzaki H, Kawano S, Tanaka T et al (2019) Clinicopathological features and outcomes of endoscopic submucosal dissection for superficial cancer of the pharynx. Acta Med Okayama 73(2):109–115. https://doi.org/10.18926/amo/56646 - DOI - PubMed
-
- Shimizu Y, Yamamoto J, Kato M, Yoshida T, Hirota J, Ono Y et al (2006) Endoscopic submucosal dissection for treatment of early stage hypopharyngeal carcinoma. Gastrointest Endosc 64(2):255–259. https://doi.org/10.1016/j.gie.2006.01.049 - DOI - PubMed
MeSH terms
Grants and funding
- 2021-I2M-1-061/CAMS Innovation Fund for Medical Sciences (CIFMS)
- 2021-I2M-1-015/CAMS Innovation Fund for Medical Sciences (CIFMS)
- 2021-I2M-1-013/CAMS Innovation Fund for Medical Sciences (CIFMS)
- 2022-I2M-C&T-B-054/CAMS Innovation Fund for Medical Sciences (CIFMS)
- No. SZSM201911008/Sanming Project of Medicine in Shenzhen
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous